Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Berliner

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Blood Advances|January 4, 2018
Clinical impact of <i>BAALC</i> expression in high-risk acute promyelocytic leukemiaAntonio R Lucena-Araujo, Diego A Pereira-Martins, Luisa C Koury, et al.
Annals of Hematology|July 2, 2014
Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia studyAntonio R Lucena-Araujo, Haesook T Kim, Rafael H Jacomo, et al.
Blood|October 3, 2015
High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemiaAntonio R Lucena-Araujo, Haesook T Kim, Carolina Thomé, et al.
Blood|July 12, 2019
Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemiaAntonio R Lucena-Araujo, Juan L Coelho-Silva, Diego A Pereira-Martins, et al.
Annals of Hematology|May 16, 2015
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studiesMiguel A Sanz, Pau Montesinos, Haesook T Kim, et al.
Transplantation and Cellular Therapy|October 9, 2025
Erratum to <Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome><[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]>Melissa R Hines, Tristan E Knight, Kevin O McNerney, et al.
Transplantation and Cellular Therapy|March 11, 2023
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like SyndromeMelissa R Hines, Tristan E Knight, Kevin O McNerney, et al.
Blood|May 28, 2024
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemiaLuísa Corrêa de Araújo Koury, Haesook T Kim, Maria Soledad Undurraga, et al.
Blood|January 16, 2013
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APLEduardo M Rego, Haesook T Kim, Guillermo J Ruiz-Argüelles, et al.
Cancers|October 30, 2020
Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic LeukemiaIsabel Weinhäuser, Diego A Pereira-Martins, Cesar Ortiz, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Blood Advances|January 4, 2018
Clinical impact of <i>BAALC</i> expression in high-risk acute promyelocytic leukemiaAntonio R Lucena-Araujo, Diego A Pereira-Martins, Luisa C Koury, et al.
Annals of Hematology|July 2, 2014
Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia studyAntonio R Lucena-Araujo, Haesook T Kim, Rafael H Jacomo, et al.
Blood|October 3, 2015
High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemiaAntonio R Lucena-Araujo, Haesook T Kim, Carolina Thomé, et al.
Blood|July 12, 2019
Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemiaAntonio R Lucena-Araujo, Juan L Coelho-Silva, Diego A Pereira-Martins, et al.
Annals of Hematology|May 16, 2015
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studiesMiguel A Sanz, Pau Montesinos, Haesook T Kim, et al.
Transplantation and Cellular Therapy|October 9, 2025
Erratum to <Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome><[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]>Melissa R Hines, Tristan E Knight, Kevin O McNerney, et al.
Transplantation and Cellular Therapy|March 11, 2023
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like SyndromeMelissa R Hines, Tristan E Knight, Kevin O McNerney, et al.
Blood|May 28, 2024
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemiaLuísa Corrêa de Araújo Koury, Haesook T Kim, Maria Soledad Undurraga, et al.
Blood|January 16, 2013
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APLEduardo M Rego, Haesook T Kim, Guillermo J Ruiz-Argüelles, et al.
Cancers|October 30, 2020
Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic LeukemiaIsabel Weinhäuser, Diego A Pereira-Martins, Cesar Ortiz, et al.
Pageof 13